OUR FOUNDING LEADERSHIP TEAM

Douglas Oliver, MSW

Founder and Board Member

Doug is a writer, editorial contributor, and patient advocate.  He holds a Master’s Degree in Social Work from the University of New England and specialized in work on health care policy and compliance..  In 2015, he underwent adult stem cell therapy for a hereditary form of Macular Degeneration to both eyes and started seeing clearly in three days.  His story reached Washington, prompting lawmakers to engage Doug for assistance in crafting key provisions in the 21st Century Cures Act, which was signed into law in 2016. CLICK HERE FOR MORE. 

Jeff Ervin, MBA

Chief Executive Officer

Jeff has more than 20 years of experience in senior corporate and financial roles. Recently, he was the Chairman and Chief Executive Officer of IMAC Holdings (Nasdaq: BACK), where he successfully launched the corporation, executed its IPO, guided a clinical trial for Parkinson’s disease and expanded the retail medical business to over 30 locations in seven states.  Jeff currently serves as an independent board member of Cingulate, Inc. (Nasdaq: CING).  He received his M.B.A from Vanderbilt University and his B.S. in finance from Miami University. 

Anthony Oliva, PhD

Chief Scientific Director

Anthony is a nationally-recognized leader in  neurosciences, specializing in neurodegenerative diseases and aging. He has served as an assistant professor at the Herbert Wertheim College of Medicine at Florida International University, and as a senior scientist at Longeveron, leading clinical programs in Alzheimer’s disease, Aging Frailty, and other indications.